Certified by Founder Lodge 
                                        
                                        Flare Therapeutics
 
                                                 United States  -  Cambridge , MA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $123,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2021
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients.
Flare is lighting up a new therapeutic space with an entire
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| March, 23 ,2023 | Series B | $123,000,000 | 
                                                
 Pfizer
                                                                                
 Casdin Capital, LLC
                                                                                
 ShangBay Capital
                                                                                
 Nextech Invest
                                                                                
                                                                            
 Novartis
                                                                                
 Third Rock Ventures
                                                                                
 Agent Capital
                                                                                
 Eventide Asset Management
                                                                                
 Boxer Capital, LLC
                                                                                
 GordonMD® Global Investments LP
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)